Stifel Downgrades Sarepta Therapeutic (SRPT) to Hold
Tweet
Share
E-mailGet Alerts SRPT Hot Sheet
Price: $18.79 -2.24%
Rating Summary:
19 Buy, 18 Hold, 6 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
19 Buy, 18 Hold, 6 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Stifel downgraded Sarepta Therapeutic (NASDAQ: SRPT) from Buy to Hold and removed its price target (prior $46).
For an analyst ratings summary and ratings history on Sarepta Therapeutic click here. For more ratings news on Sarepta Therapeutic click here.
Shares of Sarepta Therapeutic closed at $23.56 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Morgan Stanley Downgrades oOh!media (OML:AU) to Equalweight
- Deutsche Bank Downgrades Straumann Holding AG (STMN:SW) (SAUHF) to Hold
- HSBC Downgrades Ternium S.A. (TX) to Hold
Create E-mail Alert Related Categories
DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
